Filing Details
- Accession Number:
- 0000950170-23-073627
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-28 17:08:41
- Reporting Period:
- 2023-12-26
- Accepted Time:
- 2023-12-28 17:08:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1666380 | Ellen Rosenberg | 47 Hulfish Street Princeton NJ 08542 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-26 | 30,000 | $5.16 | 372,285 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-26 | 30,000 | $14.00 | 342,285 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-12-27 | 5,000 | $5.16 | 347,285 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-27 | 5,000 | $14.07 | 342,285 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2023-12-26 | 30,000 | $0.00 | 30,000 | $5.16 |
| Common Stock | Stock Options (right to buy) | Disposition | 2023-12-27 | 5,000 | $0.00 | 5,000 | $5.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 65,000 | 2026-02-08 | No | 4 | M | Direct | |
| 60,000 | 2026-02-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 15,000 | Indirect | By Spouse |
Footnotes
- This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.02 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.15 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- All of the options were fully vested and exercisable as of the transaction date.
Billionaire Hedge Funds
